Abstract: A system for flexible account creation and approval includes a computing server and a communication platform server that operates independently of the computing server. The computing server is configured to receive an account creation request initiated through interfaces of the communication platform server or the computing server. The computing server facilitates approval of the requests, which can include sending request approvers the request for review at interfaces of the communication platform server or the computing server. By enabling account creation and approval through various servers that can access the same information to provide consistent experiences, the system offers users more flexibility in choosing one of the available servers.

Abstract: The present invention relates to stable liquid pharmaceutical formulations of cyclophosphamide comprising cyclophosphamide and at least one pharmaceutically acceptable excipient wherein moisture content of the liquid formulation is less than about 2.0% by weight. The invention further relates to stable liquid formulations of cyclophosphamide prepared by a process comprising a step of reducing the moisture content from cyclophosphamide or liquid compositions of cyclophosphamide or both. The invention further relate to method of using such stable liquid formulations of cyclophosphamide for parenteral administration either as ready-to-use or ready-to-dilute for treating various cancer disorders.

Abstract: A near-eye display (NED), comprising an augmented reality (AR) lens comprising a main prism lens and a see-through corrector lens, wherein the AR lens comprises a bottom edge that tapers toward a blunt tip, and a micro-display panel coupled to the AR lens and comprising a processor configured to process content for display to a user wearing the NED, and a display coupled to the processor and configured to project the content to the AR lens.

Abstract: Disclosed are techniques for performing positioning measurements at a mobile device during a positioning session with a serving cell. In an aspect, the mobile device determines to trigger a coverage-enhanced (CE) mode before a positioning session timeout for the positioning session expires, continues performance of the positioning measurements during the positioning session with the serving cell while the mobile device remains connected to the serving cell due to the triggered CE mode, determines whether the positioning measurements have been completed or the positioning session timeout has expired, and responsive to the determination that the positioning measurements have been completed or that the positioning session timeout has expired, reports, to a network entity in the wireless communications network, actual handover measurements to enable the network entity to make a handover determination.

Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a user equipment (UE) may receive, from a network node, decoder configuration information associated with a transmitter neural network configured to be used to generate at least one latent vector corresponding to one or more computation tasks of a plurality of computation tasks associated with a query-based cross-node machine learning system. The UE may receive, from the network node, query configuration information associated with a query-based decoder. The UE may transmit, to the network node and based at least in part on instantiation of the transmitter neural network by the UE, the at least one latent vector. Numerous other aspects are described.

Abstract: Methods, systems, and devices for wireless communication are described. A user equipment (UE) may receive a carrier aggregation (CA) configuration including at least a primary component carrier (PCC) and a secondary component carrier (SCC), where the PCC is configured for frequency domain duplexed (FDD) communications and the SCC is configured for time domain duplexed (TDD) communications. To determine whether sounding reference signal (SRS) carrier switching (e.g., between the PCC and the SCC) is appropriate, the UE may monitor performance metrics. If the performance metrics fail to satisfy corresponding thresholds, the UE may reduce an SRS periodicity. For instance, the UE may request that a network entity reduce the SRS periodicity. Alternatively, the UE may reduce a quantity of antennas used for the SRS transmissions. In other examples, the UE may initiate an interchange between the PCC and the SCC such that SRS carrier switching is no longer utilized.

Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a user equipment (UE) may receive, from a network node, a transformer configuration that includes a transmitter neural network configured to be used to generate at least one latent vector corresponding to one or more channel state information (CSI) feedback tasks of a plurality of CSI feedback tasks associated with a transformer-based cross-node machine learning system, and transmit the at least one latent vector based at least in part on instantiating the transmitter neural network. Numerous other aspects are described.

Abstract: Immediate and modified release oral dosage forms of tebipenem pivoxil including dosage form cores are provided. The dosage form core includes tebipenem pivoxil in free base or salt form, and excipients including a binder, a lubricant, optionally a diluent, and optional additional excipients. The weight to weight ratio of tebipenem pivoxil to the excipients in the dosage form core is from 30:60 to 60:30. The disclosure includes methods of treating bacterial infections including complicated urinary tract infections.

Abstract: An example method of deploying a logical network platform in a virtualized computing system, the virtualized computing system including a host cluster and a virtualization management server connected to a physical network, the host cluster having hosts and a virtualization layer executing on hardware platforms of the hosts is described. The method includes receiving, at the virtualization management server, a declarative specification describing a proposed state of the logical network platform; deploying, by the virtualization management server, a network manager of the logical network platform in response to the proposed state in the declarative specification; and deploying, by the virtualization management server in cooperation with the network manager, binaries to the hosts in the host cluster.

Abstract: A polymer nanoparticle includes a polymer having repeating units of formula (I) wherein X, L1, and R1 are as defined herein. Methods of preparing the polymer nanoparticles and compositions comprising the nanoparticles are also disclosed. The polymers nanoparticles described herein are particularly useful for the treatment of bacterial biofilms.

Abstract: Aspects of adaptive trust calibration may include receiving a trust model for an occupant of an autonomous vehicle calculated based on occupant sensor data and a first scene context sensor data, and/or receiving a second scene context sensor data associated with an environment of the autonomous vehicle, determining an over trust scenario or an under trust scenario based on the trust model and a trust model threshold, and generating and implementing a human machine interface (HMI) action or a driving automation action based on the determination of the over trust scenario or the determination of the under trust scenario, and/or the second scene context sensor data.

Abstract: The disclosure provides a tebipenem pivoxil HBr formulation in the form of a tablet core comprising at least 70% (w/w) tebipenem pivoxil HBr, and in certain embodiment more than 80% (w/w) tebipenem pivoxil HBr. The disclosure provides a tebipenem pivoxil HBr tablet core comprising at least 70% w/w tebipenem pivoxil HBr, 5-25% w/w of a diluent, 0.5 to 5% w/w of a glidant, 0.5 to 5% w/w of a lubricant, and optionally 0.5 to 5% w/w of disintegrant. The disclosure provides methods of treating a patient who has a bacterial infection such as complicated urinary tract infection (cUTI), acute and chronic pyelonephritis, an upper or lower respiratory infection, or bacteremia by administering a formulation of the disclosure to the patient.

Abstract: A micromobility transit vehicle service task management system and related methods are disclosed. In one embodiment, a system determines service tasks to be executed based on a level of availability of one or more micromobility transit vehicles. A value for each of the tasks is determined based on a cost to perform the task and value generated by an increase in availability of the one or more micromobility transit vehicles, for dynamic transportation matching, from execution of the task. The tasks may be prioritized into an order of execution that maximizes a total of the values of the tasks. The determined values of the tasks may be adjusted in the prioritization of the tasks based on the order of execution of the tasks. A navigational task route may be generated based on the prioritized tasks and assigned to a technician device to guide a technician to each of the tasks.

Abstract: The disclosed embodiments relate to components of a memory system that support timing-drift calibration. In specific embodiments, this memory system contains a memory device (or multiple devices) which includes a clock distribution circuit and an oscillator circuit which can generate a frequency, wherein a change in the frequency is indicative of a timing drift of the clock distribution circuit. The memory device also includes a measurement circuit which is configured to measure the frequency of the oscillator circuit.

Abstract: The disclosure is directed to new crystalline tebipenem pivoxil salt forms, including a crystalline tebipenem pivoxil ethane sulfonate salt form (Form A), a crystalline tebipenem pivoxil ketoglutarate salt form (Form A), tebipenem pivoxil maleate salt forms (Form A and Form B), a tebipenem pivoxil malate salt form (Form A), a tebipenem pivoxil methane sulfonate salt form (Form B), a tebipenem pivoxil hydrobromide salt form (Form B), and a tebipenem pivoxil edisylate salt form (Form A). The disclosure also includes a composition, comprising a crystalline tebipenem pivoxil salt and a pharmaceutically acceptable carrier and further includes a method for treating an antibiotic resistant bacterial infection, comprising administering to a patient in need of such treatment a therapeutically effective amount of a crystalline tebipenem pivoxil salt.

Abstract: An apparatus comprises at least one processing device configured to identify issues encountered on a user interface of a web-based system, the issues being associated with data structures consolidating data from backend applications supporting the web-based system. The at least one processing device is also configured to determine which of the backend applications are the source of respective ones of the issues. The at least one processing device is further configured to generate a prioritization of the issues based at least in part on supplemental information comprising at least one of service request data and user feedback relating to the data structures. The at least one processing device is further configured to trigger the backend applications supporting the web-based system to remediate the issues based at least in part on the generated prioritization.

Abstract: Techniques are provided for computing with private healthcare data. The techniques include a de-identification method including receiving a text sequence; providing the text sequence to a plurality of entity tagging models, each of the plurality of entity tagging models being trained to tag one or more portions of the text sequence having a corresponding entity type; tagging one or more entities in the text sequence using the plurality of entity tagging models; and obfuscating each entity among the one or more tagged entities by replacing the entity with a surrogate, the surrogate being selected based on one or more attributes of the entity and maintaining characteristics similar to the entity being replaced.

Abstract: Techniques for generating a driving surface cost landscape for determining costs for vehicle positions in an environment are described herein. A planning component within a vehicle may determine a non-preferred surface associated with a type of non-preferred area of an environment along a route of a vehicle, determine a preferred surface associated with a preferred area of the environment, determine an adjusted non-preferred surface by removing an overlapping area of the non-preferred surface that overlaps the preferred surface and determine a cost associated with a vehicle position based at least on the preferred surface and the adjusted non-preferred surface. The planning component may then determine a control trajectory for the autonomous vehicle based at least in part on the cost associated with the vehicle position.

Abstract: A stator for an electric motor of a vehicle utilizes a molded terminal connector. The molded terminal connector also serves as a baffle to distribute cooling fluid around end windings of the stator. The molded terminal connector includes a non-conductive cylindrical portion and frame into which the electrically conductive terminals are molded. The terminals include a winding link that is electrically connected to the end windings and a power link that is electrically connected to the inverter.